Investigating the link between atopy and exacerbation frequency in COPD patients
The Relation Between Atopy and Frequency of Exacerbation in Chronic Obstructive Pulmonary Disease Patients
This study is trying to see if having allergies affects how often adults with COPD have flare-ups of their symptoms.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 40 Years to 70 Years |
| Sex | All |
| Sponsor | Mansoura University Hospital Academic / other |
| Locations | 1 site (Al Mansurah) |
| Trial ID | NCT06518473 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the relationship between atopy and the frequency of exacerbations in patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD). It will involve adults aged 40-70 who meet the GOLD 2024 criteria for COPD diagnosis. Participants will undergo skin prick tests to assess atopy, and their exacerbation history will be monitored. The study seeks to understand how atopy may influence the severity and frequency of COPD exacerbations.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 40-70 years diagnosed with COPD according to the GOLD 2024 criteria.
Not a fit: Patients with known allergic diseases, other chronic respiratory disorders, or significant comorbidities may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for COPD patients by identifying atopy as a contributing factor to exacerbations.
How similar studies have performed: While studies have explored the relationship between asthma and COPD, this specific investigation into atopy's role in COPD exacerbations is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 40-70 years diagnosed with COPD according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2024 criteria Exclusion Criteria: * Patients with known allergic diseases before enrollment * Patients with associated other chronic respiratory disorders * Patients with significant comorbidities that could influence respiratory function. * Recent respiratory infections or use of systemic corticosteroids within the last month before enrollment.
Where this trial is running
Al Mansurah
- Mohamed AbdElmoniem — Al Mansurah, Egypt (Recruiting)
Study contacts
- Principal investigator: Mohamed AbdElmoniem, lecturer — Lecturer of chest medicine Faculty of medicine Mansoura university
- Study coordinator: Mohamed AbdElmoniem, lecturer
- Email: dr.m1993@mans.edu.eg
- Phone: 01014008473
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.